Learn More
Medchemexpress LLC Ralaniten triacetate | 1637573-04-6 | 98.8% | 521.00 g/mol | C27H33ClO8 | 100MG

Supplier: Medchemexpress LLC HY123875A100MG
Ralaniten triacetate is the triacetate prodrug of ralaniten (EPI-506), an orally active inhibitor targeting the N-terminal domain (NTD) of the androgen receptor (AR). It is used in research to study AR signaling and has demonstrated activity against full-length AR and resistance-associated splice variants such as AR-v7. The compound is supplied in multiple solution concentrations and solid pack sizes for laboratory use.
- Prodrug designed for improved oral bioavailability.
- Targets the AR N-terminal domain to inhibit receptor activity.
- Active against full-length and variant AR forms, including AR-v7.
- Available in multiple solution concentrations and solid amounts for research use.
- High reported purity suitable for biochemical and cellular studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.